EL7.AI
StocksMedium•16 November 2026•
3 min read

Amanat Doubles Adjusted Profit to AED 154.3 Million in 9 Months of 2026

Key Facts

1Revenue was AED 767.1 million, up 23% from the comparable period.
2Adjusted EBITDA reached AED 260.7 million, up 54%.
3Adjusted profit from continuing operations was AED 154.3 million, or 2.1 times its level a year earlier.
4Reported net profit rose 16% to AED 145.3 million.

Amanat reported revenue of AED 767.1 million for the nine months ended September 30, 2026, up 23% from AED 622.1 million in the year-earlier period. Adjusted earnings before interest, taxes, depreciation and amortization rose to AED 260.7 million from AED 169.1 million a year earlier, an increase of 54%. Adjusted profit from continuing operations was AED 154.3 million, or 2.1 times its AED 72.9 million level in the comparable period. The company said performance benefited from higher patient and student numbers, improved operations and continued investment in the healthcare and education sectors. The results show adjusted profit growing faster than revenue during the period.

Adjusted EBITDA margin widened to 34%, compared with 27% a year earlier, an increase of 7 percentage points. By contrast, reported net profit, which includes continuing and discontinued operations, rose 16% to AED 145.3 million from AED 125.4 million. This figure differs from adjusted profit from continuing operations: the former reflects net results from both continuing and discontinued activities, while the adjusted figure excludes NLCS performance, non-recurring items and transaction costs. Non-recurring items in the prior period included a gain on the sale of NLCS, partly offset by a one-time impairment at Malaki Specialty Hospital. Adjusted profit therefore provides an operating comparison that excludes those items, alongside reported net profit.

At the operating level, the number of students and beneficiaries rose to about 31.2 thousand from 27.8 thousand, an increase of 12% year over year. Average inpatient numbers also increased to 549 from 429, up 28% from the same period a year earlier. In healthcare, Cambridge recorded revenue of AED 366.0 million, up 26%, while EBITDA rose 50% to AED 103.1 million. Cambridge profit was AED 45.4 million, compared with AED 12.4 million in the first nine months of 2025. The company attributed the improvement to higher patient volumes, in line with the increase in inpatients recorded during the period.

Al Masar Education generated revenue of AED 401.1 million in the first nine months of 2026, up 21% from the comparable period. Its EBITDA rose 36% to AED 174.5 million, while profit increased 28% to AED 105.6 million. This coincided with an increase in the group’s student and beneficiary numbers to about 31.2 thousand from 27.8 thousand. In the first nine months of 2025, Amanat reported revenue growth of 15% to AED 622.1 million and a 13% increase in adjusted EBITDA to AED 169.1 million. The comparison shows revenue and adjusted profit growth accelerating in the 2026 results from the prior period.

After the financial period, Amanat announced on October 27, 2026, that Cambridge had completed its acquisition of 100% of U.K. company Cornerstone Healthcare, adding 283 specialist care beds to its network. The chairman said the deal established Cambridge’s presence in the U.K. and expanded its network to more than 1,000 beds, adding that investments in Saudi Arabia and the UAE support the next phase of growth. The company is pursuing a three-year growth strategy worth AED 1.5 billion, of which it had deployed or committed about AED 900 million by the results announcement on November 13, 2026. Amanat evaluates new investments against a target return on equity of at least 10%. Cambridge’s plans in Saudi Arabia include a 155-bed specialist integrated care hospital in Riyadh and the addition of 68 rehabilitation beds in Jeddah; the three-year dividend policy targets an annual minimum of 7 fils per share.